Drug Interaction Report
3 potential interactions and/or warnings found for the following 2 drugs:
- coal tar/salicylic acid/sulfur topical
- isotretinoin
Interactions between your drugs
ISOtretinoin salicylic acid topical
Applies to: isotretinoin, coal tar/salicylic acid/sulfur topical
GENERALLY AVOID: Concomitant use of isotretinoin with topical exfoliative or keratolytic anti-acne agents may increase local skin irritation.
MANAGEMENT: Concurrent use should generally be avoided.
References (2)
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
- Pharmaceutical Society of Australia (2006) APPGuide online. Australian prescription products guide online. http://www.appco.com.au/appguide/default.asp
ISOtretinoin sulfur topical
Applies to: isotretinoin, coal tar/salicylic acid/sulfur topical
GENERALLY AVOID: Concomitant use of isotretinoin with topical exfoliative or keratolytic anti-acne agents may increase local skin irritation.
MANAGEMENT: Concurrent use should generally be avoided.
References (2)
- Cerner Multum, Inc. "UK Summary of Product Characteristics."
- Pharmaceutical Society of Australia (2006) APPGuide online. Australian prescription products guide online. http://www.appco.com.au/appguide/default.asp
Drug and food interactions
ISOtretinoin food
Applies to: isotretinoin
GENERALLY AVOID: The combined use of ethanol and isotretinoin may result in a disulfiram-like reaction. The mechanism has not been established.
MANAGEMENT: Alcohol consumption should be avoided during isotretinoin therapy.
References (1)
- (2001) "Product Information. Accutane (isotretinoin)." Roche Laboratories
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Report options
- Switch to consumer interaction data
- Email this report to a friend, doctor, or patient
- Ask questions, find answers
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Remicade
Remicade is used to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and Crohn's ...
Inflectra
Inflectra (infliximab-dyyb) is a monocloncal antibody used to treat a range of inflammatory ...
Amjevita
Amjevita is an interchangeable biosimilar to Humira used to treat rheumatoid arthritis, juvenile ...
Hyrimoz
Hyrimoz is used for ankylosing spondylitis, crohn's disease, crohn's disease, active, crohn's ...
Hadlima
Hadlima is used for ankylosing spondylitis, crohn's disease, crohn's disease, active, crohn's ...
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.